# To Compare the Safety and Efficacy of Intracameral Levofloxacin and Intracameral Cefazolin in Reducing Rates of Endophthalmitis Following Cataract Surgery.

> **NCT06710977** · EARLY_PHASE1 · COMPLETED · sponsor: **Tan Tock Seng Hospital** · enrollment: 50 (actual)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Safety of intracameral levofloxacin in cataract surgery
- **DRUG:** Use of intracameral cefazolin in cataract surgery

## Key facts

- **NCT ID:** NCT06710977
- **Lead sponsor:** Tan Tock Seng Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2024-09-01
- **Final completion:** 2024-09-01
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2024-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06710977

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06710977, "To Compare the Safety and Efficacy of Intracameral Levofloxacin and Intracameral Cefazolin in Reducing Rates of Endophthalmitis Following Cataract Surgery.". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06710977. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*